Insider · CIK 0001199105

KESSEL LARRY

Reports to the SEC for 3 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001199105

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2005-07-28	NOVADEL PHARMA INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−50K sh	—	—	0
2005-07-28	NOVADEL PHARMA INCStock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2005-06-09	KERYX BIOPHARMACEUTICALS INCStock Options (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2005-02-28	NOVADEL PHARMA INCStock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2004-05-06	NOVADEL PHARMA INCStock OptionA Award	Director	AAward	+50K sh	—	—	50,000
2004-02-04	KERYX BIOPHARMACEUTICALS INCJ Other	Director	JOther	+4,926 sh	$10.15	+$50K	10,926
2004-01-08	NOVADEL PHARMA INCEmployee Stock OptionsP Purchase	Director	PPurchase	+100K sh	—	—	100,000
2004-01-08	NOVADEL PHARMA INCWarrantsP Purchase	Director	PPurchase	+6,061 sh	—	—	6,061
2004-01-08	NOVADEL PHARMA INCP Purchase	Director	PPurchase	+20.2K sh	$1.05	+$21.2K	20,204
2004-01-01	CYPRESS BIOSCIENCE INCStock Option (right to buy)A Award	Director	AAward	+13K sh	—	—	13,000
2003-10-09	CYPRESS BIOSCIENCE INCX Exercise of In-Money	Director	XExercise of In-Money	+6,250 sh	$3.84	+$24K	199,874
2003-10-09	CYPRESS BIOSCIENCE INCCommon Stock Warrants (right to buy)X Exercise of In-Money	Director	XExercise of In-Money	−6,250 sh	—	—	0
2003-10-07	CYPRESS BIOSCIENCE INCCommon Stock Warrants (right to buy)X Exercise of In-Money	Director	XExercise of In-Money	−25K sh	—	—	0
2003-10-07	CYPRESS BIOSCIENCE INCX Exercise of In-Money	Director	XExercise of In-Money	+25K sh	$3.09	+$77.3K	193,624
2003-08-12	CYPRESS BIOSCIENCE INCP Purchase	Director	PPurchase	+5,000 sh	$4.25	+$21.3K	168,874
2003-08-11	CYPRESS BIOSCIENCE INCP Purchase	Director	PPurchase	+1,100 sh	$4.46	+$4,906	154,974
2003-08-11	CYPRESS BIOSCIENCE INCP Purchase	Director	PPurchase	+8,900 sh	$4.55	+$40.5K	163,874
2003-08-07	CYPRESS BIOSCIENCE INCP Purchase	Director	PPurchase	+20K sh	$4.95	+$99K	153,874
2003-06-23	KERYX BIOPHARMACEUTICALS INCStock Options (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000

Recent filings

Accepted (ET)
Aug 14
KESSEL LARRY0000942708-05-000159
SEC(opens sec.gov)
Jun 104
KERYX BIOPHARMACEUTICALS INC0001209191-05-031429
SEC(opens sec.gov)
Apr 264
KERYX BIOPHARMACEUTICALS INC0001209191-05-022256
SEC(opens sec.gov)
Mar 24
KESSEL LARRY0001014858-05-000006
SEC(opens sec.gov)
May 244
NOVADEL PHARMA INC0001144204-04-007599
SEC(opens sec.gov)
Jan 134
CYPRESS BIOSCIENCE INC0000716054-04-000003
SEC(opens sec.gov)
Jan 124
NOVADEL PHARMA INC0001144204-04-000219
SEC(opens sec.gov)
Oct 144
CYPRESS BIOSCIENCE INC0000716054-03-000015
SEC(opens sec.gov)
Oct 94
CYPRESS BIOSCIENCE INC0000716054-03-000013
SEC(opens sec.gov)
Aug 134
CYPRESS BIOSCIENCE INC0000716054-03-000009
SEC(opens sec.gov)
Aug 84
CYPRESS BIOSCIENCE INC0000716054-03-000008
SEC(opens sec.gov)

Companies

Address

C/O KERYX BIOPHARMACEUTICALS, INC. 750 LEXINGTON AVENUE

NEW YORK, NY, 10022